Osteonectin Antibody (High Specificity)

<strong>Osteonectin Antibody (High Specificity)</strong>_x000D_ <strong>Catalog number:</strong> B2010560_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool in the study of Osteonectin (a component of the noncollagenous proteins of the bone extracellular matrix)_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> Anti-Osteonectin Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Rosset EM, Bradshaw AD. SPARC/osteonectin in mineralized tissue. Matrix Biol._x000D_ 2016 May-Jul;52-54:78-87._x000D_ _x000D_ 2: Motamed K. SPARC (osteonectin/BM-40). Int J Biochem Cell Biol. 1999_x000D_ Dec;31(12):1363-6._x000D_ _x000D_ 3: Duś-Ilnicka I, Radwan-Oczko M, Gerber H, Hałoń A. Histopathological_x000D_ assessment of oral leukoplakia. Osteonectin as possible biomarker for further_x000D_ diagnostics. Pol J Pathol. 2020;71(2):138-145._x000D_ _x000D_ 4: Rossi MK, Gnanamony M, Gondi CS. The 'SPARC' of life: Analysis of the role of_x000D_ osteonectin/SPARC in pancreatic cancer (Review). Int J Oncol. 2016_x000D_ May;48(5):1765-71._x000D_ _x000D_ 5: Ciceri P, Elli F, Cappelletti L, Tosi D, Savi F, Bulfamante G, Cozzolino M._x000D_ Osteonectin (SPARC) Expression in Vascular Calcification: In Vitro and Ex Vivo_x000D_ Studies. Calcif Tissue Int. 2016 Nov;99(5):472-480._x000D_ _x000D_ 6: Sage EH. Purification of SPARC/osteonectin. Curr Protoc Cell Biol. 2003_x000D_ Feb;Chapter 10:Unit 10.11._x000D_ _x000D_ 7: Sodek J, Zhu B, Huynh MH, Brown TJ, Ringuette M. Novel functions of the_x000D_ matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res._x000D_ 2002;43(2-3):308-19._x000D_ _x000D_ 8: Amaral CB, Leite JDS, Fonseca ABM, Ferreira AMR. Vimentin, osteocalcin and_x000D_ osteonectin expression in canine primary bone tumors: diagnostic and prognostic_x000D_ implications. Mol Biol Rep. 2018 Oct;45(5):1289-1296._x000D_ _x000D_ 9: Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S,_x000D_ Goldsmith CM, Piper JT, Vostal JG, Harms JF, Welch DR, Kleinman HK. Endogenous_x000D_ osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell_x000D_ metastasis. Cancer Res. 2005 Aug 15;65(16):7370-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/12746322/">10: Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E. Osteonectin-null_x000D_ mutation compromises osteoblast formation, maturation, and survival._x000D_ Endocrinology. 2003 Jun;144(6):2588-96. </a>_x000D_ _x000D_ <strong>Products Related to Osteonectin Antibody (High Specificity)</strong><a href="https://moleculardepot.com/product-category/Antibodies/">: Antibodies</a>